Dave Coulier discovered a second cancer diagnosis in December 2024—a p16 squamous carcinoma at the base of his tongue—just nine months after announcing he was cancer-free from non-Hodgkin lymphoma. The difference between the two diagnoses, he says, came down to one thing: a scan caught it early.
"Prognosis is very good," Coulier told Craig Melvin on the Today Show. "P16 squamous carcinoma has a 90+ curability rate." When he asked his doctors whether the new cancer was connected to his lymphoma diagnosis, they told him it was completely unrelated—two separate health events, unconnected in cause but linked in how they'll likely be treated.
Early detection as a second chance
What strikes Coulier most isn't the diagnosis itself, but the timing of its discovery. "Early detection saved my life, not just the first time but the second time as well," he said. That message has resonated far beyond celebrity health news. In the weeks after his announcement, fans began sharing their own stories—people who'd gone in for routine checkups and found something they might have otherwise missed.
We're a new kind of news feed.
Regular news is designed to drain you. We're a non-profit built to restore you. Every story we publish is scored for impact, progress, and hope.
Start Your News DetoxOne woman shared that she's been in remission for five years after womb cancer treatment. Another, just 29 years old, went to the doctor after noticing something felt off and had four polyps removed during a colonoscopy—all of which could have developed into cancer. A third person noted they'd sought care for an unrelated shoulder injury and weight loss, only to discover something more serious that warranted attention.
These aren't isolated incidents. They're the quiet proof that routine screening works, even when people aren't looking for it. Coulier has become an unlikely advocate for exactly this: colonoscopies, breast exams, prostate exams. "I hope you're getting your check-ups," he said. "They will save your life."
The Full House actor's willingness to share his diagnosis publicly—and to frame it not as a tragedy but as evidence for the power of early detection—has shifted the conversation from his illness to the systems that caught it. His fans are now watching their own bodies more carefully, booking appointments they'd postponed, listening to their instincts when something feels off.
Coulier heads into 2025 with treatment ahead, but with odds firmly in his favor and a platform he's using to remind millions that the best cancer diagnosis is the one you catch before it becomes untreatable.
